Loteprednol etabonate ophthalmic suspension

Loteprednol etabonate · Padagis US LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Loteprednol etabonate ophthalmic suspension, covering 2011-07-18 to 2024-12-13. Get the full timeline:

Most recent: FDA Approved: LOTEPREDNOL ETABONATE — Original Application (Amneal Pharmaceuticals NY LLC)